Longtime undetected microcystic adnexal carcinoma of the scalp: considerations and implications.

Oral Maxillofac Surg

Department of Oral and Maxillofacial Surgery, Klinikum Bremen-Mitte, School of Medicine of the University of Göttingen, Bremen, Germany.

Published: June 2016


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Microcystic adnexal carcinomas (MACs) are slow-growing and often asymptomatic malignant skin tumours that usually develop on the facial skin and may reach considerable size. We present an uncommon case of MAC arising on the hair-bearing scalp and discuss our experiences and considerations.

Case Report: A 58-year-old female was admitted with a histopathologically secured diagnosis of MAC of the temporal and occipital regions that had expanded to 10 × 12 cm. Magnetic resonance imaging revealed an infiltration of the skin and the subcutaneous adipose tissue. No lymphatic or haematogenic metastases were detected. Therapy consisted of resecting the tumour and reconstructing the area by applying an anterolateral thigh (ALT) flap. Histopathological evaluation revealed clear, 1-cm margins and a tumour-free periosteum. One-year postoperative follow-ups showed no evidence of recurrence, while the outcome was aesthetically pleasing.

Conclusion: When screening for skin cancer, careful attention must be paid to the scalp. Resection of MAC with clear margins is mandatory to minimize the risk of recurrence. In this case, applying an ALT perforator flap to a large defect of the hair-bearing scalp led to a very satisfying result; it should be considered in comparable cases.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10006-015-0534-1DOI Listing

Publication Analysis

Top Keywords

microcystic adnexal
8
hair-bearing scalp
8
longtime undetected
4
undetected microcystic
4
adnexal carcinoma
4
scalp
4
carcinoma scalp
4
scalp considerations
4
considerations implications
4
implications background
4

Similar Publications

Microcystic adnexal carcinoma (MAC) and eccrine cutaneous mixed tumor (ECMT) are both cutaneous adnexal tumors that may occur in the vulvar region, but are very rare at this site. Consequently, they may not enter the differential diagnosis of vulvar lesions for gynecologic pathologists in a subspecialized practice setting. Here we report a case of MAC and a case of ECMT recently diagnosed at our institution and underscore key histologic and immunophenotypic features of each lesion that can assist in their correct identification.

View Article and Find Full Text PDF

MAC is a rare adnexal tumor with nonspecific clinical presentation. Dermatologists should consider the diagnosis of MAC when there is a solitary, longstanding lesion with aberrant clinical behavior supported by typical pathological findings of sweat gland malignant changes.

View Article and Find Full Text PDF

Background: Microsecretory adenocarcinoma (MSA) is a newly identified entity in the WHO classification of salivary gland tumors characterized by MEF2C::SS18 fusion. It was previously considered as adenocarcinoma not otherwise specified (NOS). With the discovery of new gene fusions specifying distinct salivary gland tumors and restricting the diagnosis of adenocarcinoma NOS, five cases of MSA were recognized for the first time using targeted RNA sequencing.

View Article and Find Full Text PDF

Objectives: Cutaneous adnexal carcinomas (CACs) are rare skin cancers with no established treatment guidelines. Given the limited data, this study aims to explore the characteristics and outcomes of patients with CAC treated with radiation therapy (RT).

Methods: Patients diagnosed with CAC between 2000 and 2020 who received RT were included.

View Article and Find Full Text PDF

Microcystic adnexal carcinoma (MAC) is a rare, slow-growing, locally aggressive malignant, and recurring appendageal tumor. Prolonged UV exposure, immunosuppression, and radiotherapy are a few frequently associated risk factors. MAC classically presents as an asymptomatic skin coloured plaque on the face.

View Article and Find Full Text PDF